<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> from neuronal cells plays detrimental roles in <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> neurotoxicity and in focal <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> directly damages DNA, and breaks in the DNA strands activate poly(<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="1" ids="33942">ribose</z:chebi>) polymerase (PARP), which brings poly(<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="0" ids="26565">ribosyl</z:chebi>)ation of the nuclear proteins </plain></SENT>
<SENT sid="2" pm="."><plain>The excessive activation of PARP is thought to cause <z:mpath ids='MPATH_63'>depletion</z:mpath> of ATP and the energy failure resulting in cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>To clarify the involvement of poly(<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="0" ids="26565">ribosyl</z:chebi>)ation in ischemic insult, we examined poly(<z:chebi fb="13" ids="16761">ADP</z:chebi> <z:chebi fb="0" ids="26565">ribosyl</z:chebi>)ation by immunohistochemical methods and the protective effect of 3-aminobenzamide, which is a PARP inhibitor, on focal <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> using an intraluminal permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model in rats </plain></SENT>
<SENT sid="4" pm="."><plain>Poly(<z:chebi fb="13" ids="16761">ADP</z:chebi> <z:chebi fb="0" ids="26565">ribosyl</z:chebi>)ation was widely and markedly detected 2 hours after the ischemic insult in the cerebral cortex and striatum in which infarction developed 24 hours later </plain></SENT>
<SENT sid="5" pm="."><plain>The enhanced immunoreactivity of poly(<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="1" ids="33942">ribose</z:chebi>) gradually decreased, and 16 hours later, no immunoreactivity was detected </plain></SENT>
<SENT sid="6" pm="."><plain>Intraventricular administration of 3-aminobenzamide (1 to 30 mg/kg) 30 minutes before the ischemic insult decreased infarction volume in a dose-dependent manner along with the immunohistochemical reduction of poly(<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="0" ids="26565">ribosyl</z:chebi>)ation </plain></SENT>
<SENT sid="7" pm="."><plain>Pretreatment with 7-nitroindazole (25 mg/kg, intraperitoneally), a selective neuronal nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthetase inhibitor, partially reduced poly(<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="0" ids="26565">ribosyl</z:chebi>)ation </plain></SENT>
<SENT sid="8" pm="."><plain>These data suggest the involvement of poly(<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="0" ids="26565">ribosyl</z:chebi>)ation in the development of <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
</text></document>